the parliamentary mission announced by Emmanuel Macron “is important”, underlines the professor who will participate in it

Florence Trémollières hopes to “mobilize actors from civil society” and “personalities”.

The parliamentary mission on menopause announced by Emmanuel Macron “is important, since it will affect a period in the life of all women”, underlines, Wednesday May 8 on franceinfo, Florence Trémollières. The director of the Menopause Center at Toulouse University Hospital will participate. This mission “will be used above all to provide information on what menopause is, and to implement actions to prevent all the consequences”she explains.

The President of the Republic announces this parliamentary mission in Elle magazine. He waits for her “takes stock of the current management of menopause (treatments, support, osteoporosis, cardio and psychological monitoring) and the difficulties encountered by women in terms of information and monitoring”. This phenomenon “is a real taboo in society”he emphasizes.

“Make women understand that it is far from being a taboo”

“We need to talk” menopause and “to make women understand that it is far from being a taboo”, abounds in Florence Trémollières. “All women will spend nearly 30 years of their life in a situation of hormonal deficiency. For some, it is far from neutral,” she explains. She brings up problems “not negligible in terms of public health”.

To inform about menopause, “we will try to mobilize actors from civil society and, I hope, personalities who will agree to talk about theirs”, indicates the professor of medical gynecology. She cites the example of the United Kingdom and the province of Quebec, Canada, “where women known to the general public spoke about this phenomenon, without any taboo, and thereby raised awareness” on menopause.

The “safest and most effective” hormonal treatment

In Elle, Emmanuel Macron declares that he has “also requested that we contact the High Health Authority so that it defines a practice and guidelines on hormonal treatments during menopause” because “Today, many women think that treatments are not suitable.” The head of state “wishes to obtain clear recommendations”.

Florence Trémollières cites a study in which she participated, “two years ago”. At the time, “there were only 6% women” menopausal “who were taking hormonal treatment”. Gold, “the benefits far outweigh the risks when you take this treatment at the very beginning of menopause or, overall, in the first ten years of physiological menopause which would occur at age 50.”

“These are hormones that are strictly identical to those produced by the human body”she explains again, and “we can consider that we currently have a hormonal treatment in France which is probably, among all those that exist in the world, the safest and most effective.”